1. Home
  2. BIIB vs PRU Comparison

BIIB vs PRU Comparison

Compare BIIB & PRU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Biogen Inc.

BIIB

Biogen Inc.

N/A

Current Price

$249.28

Market Cap

34.5B

Sector

Health Care

ML Signal

N/A

Logo Prudential Financial Inc.

PRU

Prudential Financial Inc.

N/A

Current Price

$121.73

Market Cap

39.0B

Sector

Finance

ML Signal

N/A

Company Overview

Basic Information
Metric
BIIB
PRU
Founded
1978
1875
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Life Insurance
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
34.5B
39.0B
IPO Year
1996
2001

Fundamental Metrics

Financial Performance
Metric
BIIB
PRU
Price
$249.28
$121.73
Analyst Decision
Buy
Hold
Analyst Count
36
18
Target Price
★ $268.26
$115.53
AVG Volume (30 Days)
1.1M
★ 1.7M
Earning Date
10-28-2026
11-03-2026
Dividend Yield
N/A
★ 4.58%
EPS Growth
N/A
★ 33.20
EPS
2.66
★ 8.43
Revenue
$9,890,600,000.00
★ $60,774,000,000.00
Revenue This Year
$6.92
N/A
Revenue Next Year
$1.91
$1.51
P/E Ratio
$94.29
★ $14.52
Revenue Growth
★ 2.22
N/A
52 Week Low
$160.36
$91.89
52 Week High
$261.00
$128.78

Technical Indicators

Market Signals
Indicator
BIIB
PRU
Relative Strength Index (RSI) 54.04 55.14
Support Level $240.00 $116.52
Resistance Level $259.89 $125.55
Average True Range (ATR) 7.29 2.73
MACD -1.09 0.12
Stochastic Oscillator 43.79 45.10

Price Performance

Historical Comparison
BIIB
PRU

About BIIB Biogen Inc.

Biogen is an established biopharmaceutical company focused on treatments for neurodegenerative and rare diseases. Its declining multiple sclerosis franchise is its largest revenue generator and contributed 40% of total revenue in 2025. Biogen also generates significant revenue from its CD20 collaboration agreements with Roche (19% of total in 2025), which includes oncology drugs Rituxan and Gazyva and multiple sclerosis drug Ocrevus. Biogen's newer franchises include Spinraza (spinal muscular atrophy, with partner Ionis), Leqembi (Alzheimer's disease, collabroation revenue from its partner Eisai), Skyclarys (Friedreich's ataxia, Reata), Zurzuvae (postpartum depression, Sage), and Qalsody (amyotrophic lateral sclerosis, Ionis).

About PRU Prudential Financial Inc.

Prudential Financial is one of the largest US life insurers, offering annuities, life insurance, and asset-management products. The United States and Japan are its two largest markets. Its US business contributed about 50% of adjusted 2025 earnings and includes institutional retirement (mostly pension risk transfer), individual retirement (annuities), group insurance, and individual life insurance. Its international business represented about 39% of adjusted earnings, with a strong market position in Japan, and the firm also has a presence in emerging markets like Brazil. The company's investment management business, PGIM, contributed approximately 11% of its 2025 adjusted earnings. PGIM had around $1.47 trillion in assets under management at the end of fourth-quarter 2025.

Share on Social Networks: